Treating type 2 diabetes mellitus: a growing epidemic

Editorial

Ruth S Weinstock. Mayo Clin Proc. 2003 Apr.

. 2003 Apr;78(4):411-3.

doi: 10.4065/78.4.411.

No abstract available

Comment on

Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus.
Gerich JE. Gerich JE. Mayo Clin Proc. 2003 Apr;78(4):447-56. doi: 10.4065/78.4.447. Mayo Clin Proc. 2003. PMID: 12683697 Review.
Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin.
Chan JL, Abrahamson MJ. Chan JL, et al. Mayo Clin Proc. 2003 Apr;78(4):459-67. doi: 10.4065/78.4.459. Mayo Clin Proc. 2003. PMID: 12683698 Review.
Insulin sensitizers.
Zangeneh F, Kudva YC, Basu A. Zangeneh F, et al. Mayo Clin Proc. 2003 Apr;78(4):471-9. doi: 10.4065/78.4.471. Mayo Clin Proc. 2003. PMID: 12683699 Review.